Pharmaceutical Sciences
Pharmaceutical Sciences covers research areas of nanomedicine, drug delivery; drug metabolism, pharmacokinetics and toxicology; pharmacogenomics and pharmacogenetics; diabetes, cardiovascular and molecular pharmacology; neuropharmacology; cancer pharmacology; pharmaceutical health outcomes and pharmacotherapeutics; and pharmaceutical education.
Faculty Members
| Name | Research Interests |
|---|---|
| Burt, Helen Mary | Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery |
| Cairns, Brian | Neuropharmacology, Oro-Facial Pain, Pain, Electrophysiology, pain mechanisms, headache, temporomandibular disorders, sex-related differences, peripheral analgesics |
| Chang, Thomas | Drug Metabolism, Pharmacology, Nuclear Receptor, Drug-Metabolizing Enzymes, Cytochrome P450, Gene Expression, Gene regulation |
| Collier, Abby | Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics |
| Conklin, Annalijn | Chronic Diseases in Elderly, Gender Epidemiology, Health Policies, Professional Practices, Obesity, Social Determinants of Dietary and Metabolic Disorders, Community Health / Public Health, healthy ageing, social nutritional epidemiology, obesity & CVD risk factors, food and nutrition policy, Indigenous health, gender and health equity, healthcare quality improvement, disease management evaluation |
| Coughtrie, Michael | Drug metabolizing enzymes |
| Cragg, Jacquelyn | Drug Effectiveness, Drug Safety, Epidemiology, SCI Progression, neuro-analytics, Neurological diseases, Parkinson’s disease, Amyotrophic Lateral Sclerosis (ALS), multiple sclerosis |
| De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
| Frankel, Adam | Biological and Biochemical Mechanisms, Bioactive Molecules, Organic Molecules and Biomolecules, Proteins, Protein Biochemistry, arginine methylation, post-translational modifications, drug discovery, yeast, autophagy, Chemical Biology |
| Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
| Hafeli, Urs | Pharmacokinetics, Imaging, Radiotherapy, Immunotherapy, Development of Drug Delivery Systems, Radiopharmaceuticals, Radioimmunotherapy, Magnetic Targeting, Targeted Drug Delivery, Novel polymers, Nanoparticles, Microspheres, Microneedles, Bioconjugates |
| Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
| Hedtrich, Sarah | Nanotechnologies, Structural Tissue Engineering / Biomaterials, Inflammatory Respiratory Diseases, Skin, Novel therapies for inflammatory and genetic diseases of human epithelia, Tissue Regeneration and Wound Healing, Topical drug delivery and Nanomedicine, New Biomedical Approaches - Alternatives to Animal Testing |
| Jarvis-Selinger, Sandra Ann | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
| Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
| Lalji, Fawziah | Pharmacoepidemiology, Infectious Diseases, Vaccination, Antibiotics and Resistance, Tuberculosis |
| Li, Shyh-dar | drug delivery, pharmaceutics, nanomedicine, biopharmaceutics |
| Loewen, Peter | Cardiovascular Diseases, Arrhythmia, Thrombosis and Embolism, Heart Failure, Pharmacoepidemiology, Stroke, Health Care Technologies, Professional Practices, Hematology, Decision Making, atrial fibrillation, stroke prevention therapy, adherence to medication, Shared decision-making, pharmacy practice, knowledge translation of evidence to patient care, patient education, clinical prediction rules, prediction of stroke and bleeding in atrial fibrillation patients, patient decision aids, patient complexiometry, healthcare communication technologies, use of mobile technology for clinical decision-making, hospital pharmacy practice, quality of care, quality drug therapy |
| Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
| McCormack, James | Knowledge translation and evidence-based practice |
| Nislow, Corey | genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing |
| Page, Brent | Cell Signaling and Cancer, drug discovery, Drug development, Medicinal Chemistry, Chemical Biology, Cancer, Target Engagement, Cell signaling |
| Rodrigues, Brian | Diabetes, Cardiomyopathy, Heart Failure, Energy Metabolism, Cardiovascular metabolism, Endothelial cell - cardiomyocyte crosstalk, Vascular Endothelial Growth factors |
| Ross, Colin | Biomedical Technologies, Gene Therapy, Drug Metabolism, Transgenic Model, Pharmacogenomics, Gene-based therapeutics, Precision Medicine |
| Sadatsafavi, Mohsen | respiratory medicine with the aim of improving patient outcomes and the efficiency of health care delivery through evidence-informed decision making at all levels of care |
| Soja, Peter | how synaptic transmission through identified ascending spinal sensory pathways and motoneuron pools differs during distinct behavioral states such as non-rapid eye movement (NREM) and REM sleep, or general anesthesia vs. wakefulness |
| Turgeon, Ricky | Cardiovascular Diseases, Heart Failure, Coronary Heart Diseases, Health Prevention, Quality of Life and Aging, Decision Making, Pharmacoepidemiology, Meta-Analysis, Professional Practices, Heart failure pharmacotherapy, Acute coronary syndromes / myocardial infarction, Cardiovascular risk reduction (lipid-lowering therapy, antiplatelet therapy), Cardiovascular safety of medications, Drug Effectiveness, Evidence-based practice, Shared decision making, Point-of-care decision aids / decision support tools, Knowledge translation / implementation, Risk calculators / clinical prediction tools, Pharmacist scope of practice, Clinical assessment / physical examination |
| Wilbur, Kerry | Professional Practices, Education Systems, workplace-based learning, culture and health professional education, patient and medication safety, interprofessional education, public health roles of pharmacists |
| Williams, Karla | Oncology |
| Wong, Judy | Carcinogenesis, cancer, aging, genetics, chromosome stability, cancer biology, pharmacology, pharmacognetics, human genetics, genomes, DNA, genomics |
| Wong, Harvey | applications of translational modeling and simulation techniques to optimize drug dose and regimen for new therapeutics, and to better understand emergence of cancer tumor drug resistance |
| Zed, Peter | Pharmacotherapy, cardiovascular disease, infectious disease, airway pharmacology, sedation and analgesia, evidence-based medicine, adverse drug events, Pharmacotherapy best practice in emergency medicine and patient safety, particularly adverse drug events |
